Genomics transforms how we understand ourselves and the world around us. Our research fuels innovative ways to study, diagnose and treat disease. It paves the way to aggregate data, analyze it, and interpret it for meaningful insights. See the latest here.
Recent Articles
Featured Publications
- Chen, X, et al. Spinal muscular atrophy diagnosis and carrier screening from genome sequencing data. Genetics in Medicine. 2020;22(5):945-953.
- Dolzhenko, E, et al. ExpansionHunter Denovo: A computational method for locating known and novel repeat expansions in short-read sequencing data. Genome Biology. 2020;21(1):102.
- Dolzhenko, E, et al. Detection of long repeat expansions from PCR-free whole-genome sequence data. Genome Research. 2017;27(11):1895-1903.
- Jaganathan, K, et. al. Predicting splicing from primary sequence with deep learning. Cell. 2019;176(3):535-548.
- Sundaram, Lakshmi at. al. Predicting the clinical impact of human mutation with deep neural networks. Nat Genet. 2018;50(8):1161-1170.
- Chen, X, et al. Cyrius: accurate CYP2D6 genotyping using whole genome sequencing data. biorXiv. 2020.
Multimedia Highlights
Podcasts
Listen as leading scientists discuss the impact of genomics and hear directly from the people whose work is shaping discovery.
iCommunity
Access in-the-field research news, customer experiences, and the latest in product developments.
Customer Videos
Gain insight by watching webinars, scientific reviews, product introductions, and more.
In the News
| Date | Publication | Title |
|---|---|---|
| Jan 13, 2021 | Clinical Lab Products | Myriad Genetics, Illumina Form Strategic Partnership in Oncology |
| Jan 13, 2021 | Clinical Lab Products | Illumina Partners with 4 Companies to Advance Genomic Profiling for Oncology |
| Jan 12, 2021 | Fierce Biotech | JPM: Illumina inks multiple cancer diagnostic partnerships to complement upcoming Grail acquisition |
| Jan 11, 2021 | Bio-IT World | Illumina at JPM: Cloud Analytics Platform, More Diagnostics Focus, Sequencing Updates To Come |
| Jan 11, 2021 | CNBC Closing Bell | Illumina CEO on 2021 outlook and tracking new coronavirus strains |
Careers at Illumina
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for Jobs